Category Archives: Sulfonylurea

You’ve Just Been Diagnosed With Type 2: Five Things to Keep in Mind

By Patrick Totty You’ve just been diagnosed with type 2 diabetes. It doesn’t matter whether your doctor looked you in the eyes with a kindly gaze when he dropped the bomb, or she just told you straight with no preliminaries: “you have diabetes.” If you’re feeling shell-shocked right now, it’s a perfectly normal reaction to … Continue reading You’ve Just Been Diagnosed With Type 2: Five Things to Keep in Mind

Life With Type 2: The Power of Naming

This is not a religious essay, so please don’t take the example below wrong. In Genesis, after God creates Adam, he tells him to go about naming the things that God has created-the animals, plants, and landscapes of the newly made world. Adam runs off, pleased to do God’s bidding, naming stuff right and left.Whether … Continue reading Life With Type 2: The Power of Naming

Dapagliflozin Teams Well With Metformin, Sulfonylurea

According to researchers, dapagliflozin, a diabetes drug developed jointly by two pharmaceutical companies has shown significant benefits when teamed with metformin and sulfonylurea. The drug, already available in Europe, is produced by Bristol-Myers and AstraZeneca. It has been shown to improve blood sugar levels, help reduce body weight, and lead to lower A1c levels when … Continue reading Dapagliflozin Teams Well With Metformin, Sulfonylurea

Maryland Researchers Enrolling Type 2 Patients in Long-Term Drug Study

BALTIMORE-Researchers at the University of Maryland School of Medicine are enrolling patients with type 2 diabetes into an NIH-funded clinical trial to evaluate the long-term benefits and risks of four widely used diabetes drugs in combination with metformin, the most common first-line medication. The University of Maryland Medical Center and the Baltimore VA Medical Center, … Continue reading Maryland Researchers Enrolling Type 2 Patients in Long-Term Drug Study

A Conversation About Janumet and Earlier Combination Therapy for Type 2 Diabetes

Combination therapy, in which doctors prescribe more than one drug to treat type 2 diabetes, is a fairly common practice. However, most newly diagnosed type 2 patients start off with metformin or a sulfonylurea and don’t go on a two-drug therapy until their first drug begins to lose its effectiveness.

But combination therapy could soon become … Continue reading A Conversation About Janumet and Earlier Combination Therapy for Type 2 Diabetes